img

Global Insulin Delivery Devices Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034


Published on: 2024-01-04 | No of Pages : 411 | Industry : Medical Devices & Consumables

Publisher : GRD Survey | Format : PDF

Global Insulin Delivery Devices Industry Outlook 2024: Overview, Opportunities, Key Companies and Forecast to 2034

Executive Summary

According to GRD Survey data, the global Insulin Delivery Devices market is estimated at 10800 million US$ in 2021 and is expected to reach 14400 million US$ by the end of 2028, growing at a CAGR of 4.2% in the forecast period between 2022 and 2028.

This report studies the Insulin Delivery Devices market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Insulin Delivery Devices in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Insulin Pens
Insulin Pumps
Insulin Syringes
Others

Market Snapshot, By Application
Patients/Homecare
Hospitals & Clinics

Main Market Players Analyzed in this report, including
Ypsomed
West Pharma
Valeritas
Tandem Diabetes Care
SOOIL
Sanofi
Roche
Owen Mumford
Novo Nordisk
Medtronic
MannKind
Insulet
Eli Lilly
Debiotech
Dance Biopharm
Copernicus
Cellnovo
Beta Bionics
BD
Animas

The study objectives of this report are
To study and analyze the global Insulin Delivery Devices market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Insulin Delivery Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Insulin Delivery Devices manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Insulin Delivery Devices market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Insulin Delivery Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Insulin Delivery Devices are as follows
History Year2016-2020
Base Year2020
Estimated Year2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Global Insulin Delivery Devices Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028.pdf

List of Figure

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Insulin Delivery Devices Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Insulin Delivery Devices Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Insulin Delivery Devices

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Insulin Delivery Devices Sales Channel and Distributors Analysis
3.3.1 Insulin Delivery Devices Sales Channel
3.3.2 Insulin Delivery Devices Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Patients/Homecare
3.4.2 Major Buyers in Hospitals & Clinics
3.5 Insulin Delivery Devices Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Insulin Delivery Devices Type Introduction
4.1.1 Insulin Pens
4.1.2 Insulin Pumps
4.1.3 Insulin Syringes
4.1.4 Others
4.2 Global Insulin Delivery Devices Sales by Type 2016-2021
4.3 Global Insulin Delivery Devices Revenue by Type 2016-2021
4.4 Global Insulin Delivery Devices Price by Type 2016-2021

5 Market Segment: by Application
5.1 Insulin Delivery Devices Type Introduction
5.1.1 Patients/Homecare
5.1.2 Hospitals & Clinics
5.2 Global Insulin Delivery Devices Sales by Application 2016-2021
5.3 Global Insulin Delivery Devices Revenue by Application 2016-2021
5.4 Global Insulin Delivery Devices Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Insulin Delivery Devices Market by Region
6.1.1 Global Insulin Delivery Devices Sales by Regions
6.1.2 Global Insulin Delivery Devices Revenue by Regions
6.2 North America Insulin Delivery Devices Market 2016-2021
6.3 Europe Insulin Delivery Devices Market 2016-2021
6.4 Asia Pacific Insulin Delivery Devices Market 2016-2021
6.5 South America Insulin Delivery Devices Market 2016-2021
6.6 Middle East and Africa Insulin Delivery Devices Market 2016-2021

7 North America
7.1 North America Insulin Delivery Devices Market by Country 2016-2021
7.1.1 North America Insulin Delivery Devices Sales by Country
7.1.2 North America Insulin Delivery Devices Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Insulin Delivery Devices Market by Country 2016-2021
8.1.1 Europe Insulin Delivery Devices Sales by Country
8.1.2 Europe Insulin Delivery Devices Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Insulin Delivery Devices Market by Country 2016-2021
9.1.1 Asia Pacific Insulin Delivery Devices Sales by Country
9.1.2 Asia Pacific Insulin Delivery Devices Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Insulin Delivery Devices Market by Country 2016-2021
10.1.1 South America Insulin Delivery Devices Sales by Country
10.1.2 South America Insulin Delivery Devices Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Insulin Delivery Devices Market by Country 2016-2021
11.1.1 Middle East and Africa Insulin Delivery Devices Sales by Country
11.1.2 Middle East and Africa Insulin Delivery Devices Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Ypsomed
12.1.1 Ypsomed Company Information
12.1.2 Ypsomed Insulin Delivery Devices Product Portfolio, Specification and Application
12.1.3 Ypsomed Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Ypsomed Key Development
12.2 West Pharma
12.2.1 West Pharma Company Information
12.2.2 West Pharma Insulin Delivery Devices Product Portfolio, Specification and Application
12.2.3 West Pharma Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 West Pharma Key Development
12.3 Valeritas
12.3.1 Valeritas Company Information
12.3.2 Valeritas Insulin Delivery Devices Product Portfolio, Specification and Application
12.3.3 Valeritas Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Valeritas Key Development
12.4 Tandem Diabetes Care
12.4.1 Tandem Diabetes Care Company Information
12.4.2 Tandem Diabetes Care Insulin Delivery Devices Product Portfolio, Specification and Application
12.4.3 Tandem Diabetes Care Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Tandem Diabetes Care Key Development
12.5 SOOIL
12.5.1 SOOIL Company Information
12.5.2 SOOIL Insulin Delivery Devices Product Portfolio, Specification and Application
12.5.3 SOOIL Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 SOOIL Key Development
12.6 Sanofi
12.6.1 Sanofi Company Information
12.6.2 Sanofi Insulin Delivery Devices Product Portfolio, Specification and Application
12.6.3 Sanofi Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Sanofi Key Development
12.7 Roche
12.7.1 Roche Company Information
12.7.2 Roche Insulin Delivery Devices Product Portfolio, Specification and Application
12.7.3 Roche Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Sanofi Key Development
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Information
12.9.2 Novo Nordisk Insulin Delivery Devices Product Portfolio, Specification and Application
12.9.3 Novo Nordisk Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Novo Nordisk Key Development
12.8 Owen Mumford
12.8.1 Owen Mumford Company Information
12.8.2 Owen Mumford Insulin Delivery Devices Product Portfolio, Specification and Application
12.8.3 Owen Mumford Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Owen Mumford Key Development
12.11 MannKind
12.11.1 MannKind Company Information
12.11.2 MannKind Insulin Delivery Devices Product Portfolio, Specification and Application
12.11.3 MannKind Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 MannKind Key Development
12.12 Insulet
12.12.1 Insulet Company Information
12.12.2 Insulet Insulin Delivery Devices Product Portfolio, Specification and Application
12.12.3 Insulet Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Insulet Key Development
12.13 Eli Lilly
12.13.1 Eli Lilly Company Information
12.13.2 Eli Lilly Insulin Delivery Devices Product Portfolio, Specification and Application
12.13.3 Eli Lilly Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Eli Lilly Key Development
12.14 Debiotech
12.14.1 Debiotech Company Information
12.14.2 Debiotech Insulin Delivery Devices Product Portfolio, Specification and Application
12.14.3 Debiotech Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Debiotech Key Development
12.15 Dance Biopharm
12.15.1 Dance Biopharm Company Information
12.15.2 Dance Biopharm Insulin Delivery Devices Product Portfolio, Specification and Application
12.15.3 Dance Biopharm Insulin Delivery Devices Sales, Price, Revenue and Gross Margin (2019-2021)
12.15.4 Dance Biopharm Key Development
12.17 Cellnovo
12.18 Beta Bionics
12.19 BD
12.20 Animas

13 Global Insulin Delivery Devices Market Forecast by Region by Type and by Application
13.1 Global Insulin Delivery Devices Sales, Revenue Forecast 2022-2027
13.2 Global Insulin Delivery Devices Forecast by Regions
13.2.1 Global Insulin Delivery Devices Sales Forecast by Region 2022-2027
13.2.2 Global Insulin Delivery Devices Revenue Forecast by Region 2022-2027
13.3 Global Insulin Delivery Devices Forecast by Type
13.3.1 Global Insulin Delivery Devices Sales Forecast by Type 2022-2027
13.3.2 Global Insulin Delivery Devices Revenue Forecast by Type 2022-2027
13.3.3 Global Insulin Delivery Devices Price Forecast by Type 2022-2027
13.4 Global Insulin Delivery Devices Forecast by Application
13.4.1 Global Insulin Delivery Devices Sales Forecast by Application 2022-2027
13.4.2 Global Insulin Delivery Devices Revenue Forecast by Application 2022-2027
13.4.3 Global Insulin Delivery Devices Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer